Viewing Study NCT02598427

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-04-24 @ 9:16 AM
Study NCT ID: NCT02598427
Status: TERMINATED
Last Update Posted: 2018-02-28
First Post: 2015-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer
Sponsor: Kimberly Blackwell
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Positive Untreated Metastatic Breast Cancer View
None Asymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None HER2 Positive View
None HER2+ View
None Brain Metastases View
None Metastatic Breast Cancer View
None Intrathecal Treatment View
None Lumbar Puncture View
None Pertuzumab View
None Trastuzumab View
None Advanced Breast Cancer View
None Duke University View